Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sandra D. Griego is active.

Publication


Featured researches published by Sandra D. Griego.


Journal of Immunology | 2000

Role of p38 Mitogen-Activated Protein Kinase in Rhinovirus-Induced Cytokine Production by Bronchial Epithelial Cells

Sandra D. Griego; Cynthia Weston; Jerry L. Adams; Ruth Tal-Singer; Susan B. Dillon

The stress-activated protein kinase p38 plays a central role in the regulation of cytokine biosynthesis by various cell types in response to a wide range of stimuli. Because the local inflammatory response and the infiltration of neutrophils is thought to contribute to the symptoms and sequelae of rhinovirus infection, we investigated the role of p38 kinase in cytokine and chemokine elaboration in airway epithelial cells infected with human rhinovirus. Rhinovirus-39 infection of BEAS-2B cells resulted in synthesis of cytokines (IL-1, IL-6, G-CSF, and GM-CSF) and CXC chemokines (IL-8, epithelial neutrophil-activating protein-78, and growth-related oncogene-α), evident 24–72 h postinfection. Rhinovirus infection induced a time- and dose-dependent increase in tyrosine phosphorylation of p38 kinase, which peaked 30 min postinfection and remained elevated for 1 h. Treatment of infected cells with SB 239063, a potent pyridinyl imidazole inhibitor of p38 kinase, resulted in up to 100% inhibition of mediator production and partially reduced levels of IL-8 mRNA as determined by quantitative RT-PCR. Treatment with SB 239063 had no effect on virus replication and was not cytotoxic at concentrations ≤ 70 μM. These studies provide the first evidence that early activation of p38 kinase by rhinovirus infection is a key event in regulation of virus-induced cytokine transcription, and may provide a new target for inhibition of symptoms and airway inflammation associated with rhinovirus infection.


Journal of Immunological Methods | 2002

Progressive epitope-blocked panning of a phage library for isolation of human RSV antibodies

Ping Tsui; Mark A. Tornetta; Robert S. Ames; Carol Silverman; Terence G. Porter; Cynthia Weston; Sandra D. Griego; Raymond W. Sweet

Epitope-blocked panning is an approach to mining antigen-specific diversity from phage display antibody libraries. Previously, we developed and used this method to recover a neutralizing antibody to respiratory syncytial virus (RSV) by blocking a dominant response to a nonneutralizing epitope on a recombinant derivative of the viral F antigen. We have extended this approach to the blocking of multiple epitopes simultaneously, which led to the recovery of new antibodies of different specificity, including one new neutralizing activity. A phage display Fab library was selected on recombinant F antigen in the presence of three representative antibodies recovered in the unblocked and subsequent single-blocked panning procedures. Restriction endonuclease fingerprinting of 13 F+ clones revealed seven unique Fabs. DNA sequence analysis of five of these clones revealed five new light chains in combination with different heavy chains, three of which were very similar or identical to Fabs previously isolated from this library. The blocking antibodies did not compete with the new Fabs, demonstrating effective masking of their binding sites in the panning procedure. Conversely, these Fabs did show variable inhibition of two of the blocking antibodies suggesting a close proximity or interdependence of their epitopes. One of the antibodies did inhibit virus infection, albeit with modest potency. These results demonstrate that epitope-blocked panning is a self-progressing approach to retrieving diverse antibodies from phage libraries.


Archive | 1996

Substituted imidazoles having anti-cancer and cytokine inhibitory activity

Jerry Leroy Adams; Susan B. Dillon; Sandra D. Griego; Dennis Lee


Journal of Biological Chemistry | 1995

Heavy Chain Dimers as Well as Complete Antibodies Are Efficiently Formed and Secreted from Drosophila via a BiP-mediated Pathway

Robert B. Kirkpatrick; Subinay Ganguly; Monica Angelichio; Sandra D. Griego; Allan R. Shatzman; Carol Silverman; Martin Rosenberg


Journal of Immunology | 1996

Isolation of a neutralizing human RSV antibody from a dominant, non-neutralizing immune repertoire by epitope-blocked panning.

Ping Tsui; M A Tornetta; Robert S. Ames; B C Bankosky; Sandra D. Griego; C Silverman; Terence G. Porter; G Moore; R W Sweet


Archive | 1999

Novel 2-alkyl substituted imidazole compounds

Jerry Leroy Adams; Dennis Lee; Susan B. Dillon; Sandra D. Griego


Archive | 2000

Use of csaids in rhinovirus infection

Susan B. Dillon; Sandra D. Griego


Archive | 2000

Utilisation de csaids contre l'infection par rhinovirus

Susan B. Dillon; Sandra D. Griego


Archive | 2000

Verwendung von csaids bei rhinovirus-infektionen

Susan B. Dillon; Sandra D. Griego


Archive | 1999

Nouveaux composes d'imidazole a substitution alkyle en position 2

Jerry Leroy Adams; Dennis Lee; Susan B. Dillon; Sandra D. Griego

Collaboration


Dive into the Sandra D. Griego's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dennis Lee

Sunesis Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carol Silverman

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge